The growth of Viagra and its impact on the drug landscape presents a complex question for shareholders. While the early sales statistics were impressive, the exclusivity has ended, leading to a flood of copycat https://mollyfvnc601685.blue-blogs.com/49598524/the-blue-pill-and-big-pharma-a-speculative-opportunity